Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2020
HLS Therapeutics reports fiscal 2019 financial results
HLS Therapeutics reported financial results for the three- and twelve-month periods ended December 31, 2019, including fiscal-year revenue of $54.2 million and adjusted EBITDA of $31.6 million.